Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

41.96
-0.5750-1.35%
Volume:6.03M
Turnover:254.05M
Market Cap:187.33B
PE:10.48
High:42.72
Open:42.47
Low:41.89
Close:42.53
52wk High:64.16
52wk Low:35.12
Shares:4.47B
Float Shares:3.19B
Volume Ratio:1.27
T/O Rate:0.19%
Dividend:1.72
Dividend Rate:4.10%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:5.75
PE(LYR):11.59

Loading ...

Will AI Save the Pharma Industry Billions? Novo's Anthropic Deal is Betting on It.

Dow Jones
·
38 mins ago

Novo Nordisk Will Use Anthropic's Claude for Drug Research

Dow Jones
·
52 mins ago

Novo Nordisk A/S Series B Stock Falls Wednesday, Underperforms Market

Dow Jones
·
1 hour ago

Novo (NVO) Partners with Anthropic on AI Drug Discoveries

TIPRANKS
·
Yesterday

Novo Nordisk announces collaboration with Anthropic

TIPRANKS
·
Yesterday

LIVE Markets-from Ozempic Face to K-Beauty Factories: the Next Beauty Bet

Reuters
·
Sep 15

Novo CEO Urges Staff to Embrace More Customer-Focused Culture

Reuters
·
Sep 15

Sector Update: Healthcare

MT Newswires Live
·
Sep 15

Novo Nordisk Stock (NVO) Is Falling Despite Rebrand to ‘Novo’ — Here’s Why

TIPRANKS
·
Sep 15

Lilly: Foundayo Has Captured Over 30% Of New Patient Share In The U.S. Oral Weight-Loss Drug Market

Bellwether Stocks Movement
·
Sep 15

Novo Nordisk rebranding as ‘Novo,’ announces cultural reset

TIPRANKS
·
Sep 15

GSK Doubles Down On Oncology: Buys Global Rights To Chimagen's Trispecific TCE For Up To $750 Million

Options & Short Sell
·
Sep 15

Lilly's Foundayo Grabs 30% Of New U.S. Orforglipron Patients, Chipping Away At Novo's Head Start

Options & Short Sell
·
Sep 15

Lilly Says Foundayo Has Captured over 30% of New US Patients on Oral Weight-Loss Drugs

Reuters
·
Sep 15

Novo Nordisk is Dropping Some Weight. it Still Faces a Bigger Challenge.

Dow Jones
·
Sep 15

Novo Nordisk A/S Series B Stock Rises Monday, Outperforms Market

Dow Jones
·
Sep 15

Dow Jones Top Company Headlines at 11 am ET: Microsoft Sets Limits for AI Models as Altman Details Control Risks | Dell's ...

Dow Jones
·
Sep 14

Novo Nordisk Kept at Hold as Analyst Maintains $47 Price Target Amid Strategic Uncertainty

TIPRANKS
·
Sep 14

Data Retention Terms Prompt Restraints on AI Model Use for Sensitive Operations

Deep News
·
Sep 14

Novo Signals New Direction of Travel with Rebrand

Dow Jones
·
Sep 14